Related Experiment Videos
Veto cells in transplantation tolerance
J M Thomas1, K M Verbanac, F M Carver
1Department of Surgery, East Carolina University School of Medicine, Greenville, NC 27858.
Clinical Transplantation
|April 1, 1994
Summary
Researchers achieved long-term kidney transplant acceptance in non-human primates without chronic immunosuppression. This breakthrough utilized donor bone marrow cell infusion and rabbit antithymocyte globulin, paving the way for safer transplantation strategies.
Area of Science:
- Transplantation immunology
- Immunosuppression strategies
- Preclinical research models
Background:
- Improved graft survival via immunosuppression, but chronic drug side effects remain a challenge.
- Donor-specific unresponsiveness is key for lasting transplant success.
- Rodent tolerance models show promise but lack human applicability.
Purpose of the Study:
- To establish a preclinical model for studying transplant tolerance in non-human primates.
- To investigate a novel tolerance-inducing strategy for allogeneic kidney transplantation.
- To explore the immunological mechanisms underlying transplant tolerance.
Main Methods:
- Established a preclinical allogeneic kidney transplant model in unrelated outbred rhesus monkeys.
- Administered rabbit antithymocyte globulin post-transplant.
- Infused a subpopulation of donor bone marrow cells.
Main Results:
- Achieved long-term graft acceptance in the absence of chronic immunosuppressive drugs.
- Demonstrated the efficacy of the combined immunosuppressive and cell infusion strategy.
- Provided insights into the immunological mechanisms of tolerance induction.
Conclusions:
- The developed strategy shows potential for inducing lasting transplant tolerance without chronic immunosuppression.
- This preclinical model is valuable for advancing human transplantation research.
- Further investigation into the veto hypothesis may elucidate tolerance maintenance mechanisms.